Arcutis Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ARQT)

Historical Holders from Q1 2020 to Q3 2025

Symbol
ARQT on Nasdaq
CUSIP
03969K108
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
119M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
127M
Holdings value
$1.78B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
226
Number of buys
121
Number of sells
-110
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Arcutis Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ARQT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRUDENTIAL FINANCIAL INC 10.1% $159M 12M PRUDENTIAL FINANCIAL INC Mar 31, 2025
JENNISON ASSOCIATES LLC 9.6% $151M 11.4M Jennison Associates LLC Mar 31, 2025
Frazier Life Sciences VIII, L.P. 7.5% $142M 8.94M Patrick J. Heron Aug 18, 2025
Polar Capital Holdings Plc 4.2% -24.2% $79.3M -$26.9M 5.01M -25.3% Polar Capital Holdings Plc Jun 30, 2025

Institutional Holders of Arcutis Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ARQT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 714 $13.5K +$415 $18.85 1
2025 Q2 127M $1.78B +$21.5M $14.02 226
2025 Q1 125M $1.95B -$63.3M $15.64 238
2024 Q4 129M $1.79B +$16.1M $13.93 205
2024 Q3 128M $1.2B +$14.2M $9.30 187
2024 Q2 127M $1.18B +$21M $9.30 185
2024 Q1 109M $1.08B +$267M $9.91 125
2023 Q4 159K $515K -$27.2K $3.23 3
2023 Q3 67.1M $356M -$30M $5.31 132
2023 Q2 71.7M $683M -$6.79M $9.53 132
2023 Q1 71.6M $787M +$44.3M $11.00 139
2022 Q4 65.6M $971M +$88.1M $14.80 136
2022 Q3 59.3M $1.13B +$194M $19.11 135
2022 Q2 49.1M $1.05B +$17.6M $21.31 110
2022 Q1 48.2M $927M +$37.2M $19.26 103
2021 Q4 45.7M $948M -$2.87M $20.74 86
2021 Q3 45.7M $1.09B +$4.2M $23.89 100
2021 Q2 45.4M $1.24B -$38M $27.29 99
2021 Q1 46.8M $1.35B +$171M $28.93 91
2020 Q4 40.8M $1.15B +$134M $28.13 77
2020 Q3 34.8M $1.02B +$28.9M $29.30 60
2020 Q2 33.8M $1.02B +$33.1M $30.24 55
2020 Q1 32.7M $974M +$973M $29.80 48